CompletedNot Applicable

Evaluation of the Antibiofilmogramme® Test During Diabetic Foot Infections

France33 participantsStarted 2015-12-16

Plain-language summary

This is an observational study that does not change routine care. The primary objective of this study is to investigate the role of antibiogramme-antibiofilmogramme concordance (in terms of S. aureus strains and prescribed antibiotics) in the presence/absence of S. aureus strains at the end of a first regimen of antibiotics.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * The patient must have given his/her informed and signed consent * The patient must be insured or beneficiary of a health insurance plan * The patient is available for 7 to 10 weeks of follow-up * Patient with a foot wound (at least stage 2 or more) that is infected by at least 1 strain of S. aureus Exclusion Criteria: * The patient is participating in, or has participated in within the past 3 months, another interventional study, or is currently in an exclusion period determined by a preceding study * The patient is under judicial protection, under tutorship or curatorship * The patient refuses to sign the consent * It is impossible to correctly inform the patient * The patient is pregnant, parturient, or breastfeeding * Emergency situation precluding correct study implementation

What they're measuring

Presence/absence of S. aureus strains in the wound

Timeframe: At the end of 1st antibiotics (expected average of 21 days)

Antibiofilmogramme results

Timeframe: Baseline (Day 0)

Antibiogram results

Timeframe: Baseline (Day 0)

Trial details

NCT IDNCT02378493

SponsorCentre Hospitalier Universitaire de Nīmes

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2019-07-17

View on ClinicalTrials.gov More Diabetic Foot trials